3,4-Dichloromethylphenidate
Aliases: 3,4-ctmp, 3,4-dcmp, Dichloromethylphenidate, 34ctmp
Summary
3,4-CTMP is approximately seven times more potent than methylphenidate and has a significantly longer duration of 6-18 hours. A critical safety concern is its agonist activity at 5-HT2B receptors, which can cause pulmonary hypertension and heart valve fibrosis with repeated use. Insufflation is strongly discouraged as the substance has low water solubility, is extremely caustic to nasal tissues, and has poor absorption leading to delayed onset that increases overdose risk.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 2-4mg | 4-6mg | 6-8mg | 8mg+ |
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | Total |
|---|---|---|---|---|
| Oral | 1-2 hrs | 3-6 hrs | 4-8 hrs | 8-16 hrs |
Effect Profile
5 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong anxiety/jitters, euphoria, and focus with mild stimulation
Tolerance
Tolerance Decay
Effects
Aggregated from 5 Erowid experience reports